PUBLISHER: The Business Research Company | PRODUCT CODE: 1938742
PUBLISHER: The Business Research Company | PRODUCT CODE: 1938742
Veterinary pain management refers to a practice that utilizes medications and related products to aid in healing and recovery while diagnosing and treating the underlying conditions to uphold the health quality of an animal. This approach is designed to improve the quality of life for both pets and livestock, ensuring comfort during and after surgical procedures or in the case of chronic conditions.
The main products in veterinary pain management include drugs and devices. Drugs encompass substances, excluding food, used to cure or alleviate the symptoms of an illness or other abnormal state. These products are applied to various types of animals, including companion animals and livestock, and are distributed through channels such as hospitals and clinics, as well as pharmacy channels. Veterinary pain management products find applications in addressing issues such as joint pain, postoperative pain, cancer-related pain, and various other veterinary health concerns.
Tariffs have affected the veterinary pain management market by increasing the cost of imported drugs, devices, and related equipment, thereby impacting production and distribution expenses. Companion animal segments in North America and Europe, as well as livestock-focused regions in Asia-Pacific, are most affected due to dependency on imported veterinary products. However, tariffs have also encouraged local manufacturing and innovation, allowing companies to develop cost-effective alternatives and strengthen domestic supply chains. Overall, while costs have risen, the market is seeing increased investment in local production and technology adaptation.
The veterinary pain management market research report is one of a series of new reports from The Business Research Company that provides veterinary pain management market statistics, including veterinary pain management industry global market size, regional shares, competitors with a veterinary pain management market share, detailed veterinary pain management market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary pain management industry. This veterinary pain management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The veterinary pain management market size has grown rapidly in recent years. It will grow from $2.32 billion in 2025 to $2.57 billion in 2026 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to increasing prevalence of chronic pain in pets, rising veterinary surgical procedures, growth of companion animal population, increasing adoption of pet insurance, expansion of veterinary clinics in urban areas.
The veterinary pain management market size is expected to see rapid growth in the next few years. It will grow to $3.87 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to advancements in veterinary analgesics, development of smart pain management devices, increasing awareness of animal welfare, rise in geriatric pet population, growth of livestock healthcare programs. Major trends in the forecast period include personalized pain management solutions, minimally invasive pain management techniques, growth in postoperative care services for animals, rising awareness of animal welfare and comfort, integration of wearable monitoring devices in veterinary care.
The rising trend of pet ownership is expected to drive the growth of the veterinary pain management market going forward. Pet ownership refers to having a domestic animal, such as a dog, cat, or other pet, as part of the household. Pet ownership is increasing as more individuals seek companionship and emotional support from animals, which provides comfort and helps reduce feelings of loneliness. Veterinary pain management supports pet ownership by ensuring that pets remain healthy, comfortable, and active, strengthening the bond between owners and their animals. For example, in 2023, according to Shelter Animals Count, a US-based non-governmental organization, an estimated 6.5 million cats and dogs entered shelters and rescues across the United States. Therefore, the growing number of pet owners is driving demand for the veterinary pain management market.
Leading companies operating in the veterinary pain management market are leveraging technological advancements, such as Tractor Supply RX, to gain a competitive edge. Tractor Supply RX is an electronic prescription and delivery platform that allows veterinarians to issue, transmit, and manage prescriptions for pain management therapeutics digitally, while connecting with fulfillment services to deliver prescribed analgesics directly to clients. This approach improves access, convenience, and adherence to treatment protocols. For instance, in April 2025, Tractor Supply Company, a US-based rural lifestyle retailer, launched Tractor Supply RX, providing integrated online ordering of prescribed pain and other medications, automatic delivery through its AutoShip program, and pharmacist support to guide customers on medication use and dosing. This innovation enhances client engagement, broadens access, and supports continuity of care, while requiring careful integration with veterinary clinical workflows and regulatory compliance.
In September 2024, Boehringer Ingelheim International GmbH, a Germany-based provider of human and animal health pharmaceuticals, biologics, and therapeutic solutions, acquired Saiba Animal Health AG for an undisclosed amount. Through this acquisition, Boehringer Ingelheim strengthened its animal health research and development pipeline by integrating Saiba's innovative therapeutic vaccine technologies targeting chronic conditions, including inflammation and pain, thereby enhancing its veterinary pain management and pet therapeutics portfolio. Saiba Animal Health AG is a Switzerland-based developer of novel therapeutic medicines for companion animals, focusing on virus-like particle-based vaccines designed to address chronic conditions such as allergy, inflammation, and pain.
Major companies operating in the veterinary pain management market are CH Boehringer Sohn AG & Co. KG, Zoetis Inc., Merck & Co Inc., Elanco Animal Health Incorporated, Ceva Sante Animale, Vetoquinol SA, Norbrook Laboratories Inc., Dechra Pharmaceuticals PLC, Chanelle Pharmaceuticals Manufacturing Ltd., Assisi Animal Health, Bayer AG, Eli Lilly and Company, Novartis AG, SeQuent Scientific Limited, Eltech K-Laser srl, Virbac, Durvet Inc., Bimeda Inc., Inovet Pharma (A subsidiary of Orion Group), Zenex Animal Health India Private Ltd., AnimalCare Group PLC, Eco Animal Health Group PLC, Prodivet pharmaceuticals S. A., Henry Schein Inc., Covetrus Inc., MWI Veterinary Supply Inc., Animal Health International Inc., Midwest Veterinary Supply Inc.
North America was the largest region in the veterinary pain management market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary pain management market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the veterinary pain management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The veterinary pain management market consists of revenues earned by entities by anesthetics, opioids, nonsteroidal anti-inflammatory drugs (NSIDs), alpha-2 agonists, and disease-modifying osteoarthritis agents. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market consists of sales of laser therapy devices, electromagnetic therapy devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Veterinary Pain Management Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses veterinary pain management market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for veterinary pain management ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary pain management market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.